Precigen (NASDAQ: PGEN) revenue
Precigen reported revenue of $9.7m for fiscal 2025, 146.7% more than in fiscal 2024 ($3.9m). Since fiscal 2016 its revenue has fallen by 94.9%, an average decline of 28.2% a year.
Precigen's best year of the last 10 was fiscal 2017. The biggest drop was in fiscal 2023, −76.9%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $9.7m | +146.7% | −$110.5m | −1,141.1% |
| 2024 | $3.9m | −36.9% | −$135.0m | −3,440.2% |
| 2023 | $6.2m | −76.9% | −$99.8m | −1,602.5% |
| 2022 | $26.9m | +88.6% | −$80.0m | −297.2% |
| 2021 | $14.3m | −55.4% | −$111.0m | −777.8% |
| 2020 | $32.0m | −64.7% | −$104.5m | −326.7% |
| 2019 | $90.7m | −40.0% | −$171.3m | −188.8% |
| 2018 | $151.2m | −31.1% | −$505.6m | −334.4% |
| 2017 | $219.5m | +14.9% | −$137.9m | −62.8% |
| 2016 | $190.9m | — | −$125.2m | −65.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Precigen revenue compared with its sector
By revenue for its latest fiscal year, Precigen ranks 370th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Precigen, 146.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 368th | Zenas BioPharma | $10.0m | 100.0% |
| 369th | Taysha Gene Therapies | $9.8m | 17.3% |
| 370th | Precigen | $9.7m | 146.7% |
| 371st | Prothena Corporation Public | $9.7m | −92.8% |
| 372nd | Bioage Labs | $9.0m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Precigen
- How much revenue did Precigen make in fiscal 2025?
- Precigen reported revenue of $9.7m for fiscal 2025, compared with $3.9m in fiscal 2024.
- How much has the revenue of Precigen fallen?
- Between fiscal 2016 and fiscal 2025 it went from $190.9m to $9.7m: 94.9% less, an average decline of 28.2% a year.
- What was the best year for revenue at Precigen?
- Of its last 10 fiscal years, fiscal 2017, with $219.5m.
- Where does Precigen rank in its sector by revenue?
- It ranks 370th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Precigen come from?
- From the annual report (Form 10-K) that Precigen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Precigen files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Precigen: the Precigen page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.